Watch out, Gilead and Novartis: there's a new CAR-T in town ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner. The company has wrapped up all ...

With full confidence in China, where Novartis recorded 17 percent growth last year, one of the fastest among all major ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

BASEL, SWITZERLAND, November 11, 2024 /EINPresswire / -- On November 10th, the American Swiss Foundation's 34th Annual Young Leaders conference officially kicked off in Basel, Switzerland, sponsored ...

More More Novartis blasts US move to rein in drug prices This content ... If the campaign rhetoric on science, safety and ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Analyst Thomas Smith of Leerink Partners reiterated a Buy rating on MoonLake Immunotherapeutics (MLTX – Research Report), retaining the ...

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...